Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 24655562)

1.

Oxidative stress level is not associated with survival in terminally ill cancer patients: a preliminary study.

Yeom CH, Choi YS, Ahn HY, Lee SH, Hwang IC.

BMC Palliat Care. 2014 Mar 21;13(1):14. doi: 10.1186/1472-684X-13-14.

2.

A prospective study on C-reactive protein as a prognostic factor for survival time of terminally ill cancer patients.

Suh SY, Ahn HY.

Support Care Cancer. 2007 Jun;15(6):613-20. Epub 2007 Jan 18.

PMID:
17235502
3.

Random Serum Cortisol as a Predictor for Survival of Terminally Ill Patients With Cancer: A Preliminary Study.

Kim HM, Ha KS, Hwang IC, Ahn HY, Youn CH.

Am J Hosp Palliat Care. 2014 Dec 14. pii: 1049909114563065. [Epub ahead of print]

PMID:
25500431
4.

Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients.

Shin HS, Lee HR, Lee DC, Shim JY, Cho KH, Suh SY.

J Pain Symptom Manage. 2006 Jun;31(6):493-501.

PMID:
16793489
5.
6.

Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients.

Amir O, Paz H, Rogowski O, Barshai M, Sagiv M, Shnizer S, Reznick AZ, Amir RE.

Clin Cardiol. 2009 Apr;32(4):199-203. doi: 10.1002/clc.20317.

PMID:
19353709
7.

Development and validation of a prognostic scale for hospitalized patients with terminally ill cancer in China.

Huang Y, Xi Q, Xia S, Wang X, Liu Y, Huang C, Zheng W, Yu S.

Support Care Cancer. 2014 Jan;22(1):145-52. doi: 10.1007/s00520-013-1970-9. Epub 2013 Sep 7.

PMID:
24013570
8.

Factors associated with length of survival among 1081 terminally ill cancer patients.

Allard P, Dionne A, Potvin D.

J Palliat Care. 1995 Autumn;11(3):20-4.

PMID:
7472787
9.

Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study.

Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D.

Cancer. 1995 May 15;75(10):2613-22.

PMID:
7537625
10.

Nutritional predictors of survival in terminally ill cancer patients.

Ho SY, Guo HR, Chen HH, Peng CJ.

J Formos Med Assoc. 2003 Aug;102(8):544-50.

PMID:
14569319
11.

Antioxidant intake and status, and oxidative stress in relation to breast cancer risk: a case-control study.

Sharhar S, Normah H, Fatimah A, Fadilah RN, Rohi GA, Amin I, Cham BG, Rizal RM, Fairulnizal MN.

Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):343-49.

12.

Development of terminal cancer prognostic score as an index in terminally ill cancer patients.

Yun YH, Heo DS, Heo BY, Yoo TW, Bae JM, Ahn SH.

Oncol Rep. 2001 Jul-Aug;8(4):795-800.

PMID:
11410786
13.

Development and validation of a prognostic nomogram for terminally ill cancer patients.

Feliu J, Jiménez-Gordo AM, Madero R, Rodríguez-Aizcorbe JR, Espinosa E, Castro J, Acedo JD, Martínez B, Alonso-Babarro A, Molina R, Cámara JC, García-Paredes ML, González-Barón M.

J Natl Cancer Inst. 2011 Nov 2;103(21):1613-20. doi: 10.1093/jnci/djr388. Epub 2011 Oct 4.

14.

Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.

Bhatavdekar JM, Patel DD, Shah NG, Vora HH, Suthar TP, Chikhlikar PR, Ghosh N, Trivedi TI.

Ann Surg Oncol. 2000 May;7(4):305-11.

PMID:
10819372
15.

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Pinski JK, Quinn DI.

J Nucl Med. 2013 Aug;54(8):1195-201. doi: 10.2967/jnumed.112.114116. Epub 2013 Jun 19.

16.

Oxidative stress and antioxidant status in cancer patients and healthy subjects, a case-control study.

Adhikari D, Baxi J, Risal S, Singh PP.

Nepal Med Coll J. 2005 Dec;7(2):112-5.

PMID:
16519076
17.

Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.

Sánchez-Lara K, Turcott JG, Juárez E, Guevara P, Núñez-Valencia C, Oñate-Ocaña LF, Flores D, Arrieta O.

Nutr Cancer. 2012;64(4):526-34. doi: 10.1080/01635581.2012.668744. Epub 2012 Apr 10.

PMID:
22489794
18.

Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.

Singh P, Tripcony L, Nicklin J.

Int J Gynecol Cancer. 2012 Jan;22(1):115-22. doi: 10.1097/IGC.0b013e31822fa8bb.

PMID:
21997176
19.

Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?

Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J.

Lung Cancer. 2007 Mar;55(3):263-70. Epub 2007 Jan 17.

PMID:
17207891
20.

Evaluation of oxidative stress, antioxidant status and serum vitamin C levels in cancer patients.

Mahdavi R, Faramarzi E, Seyedrezazadeh E, Mohammad-Zadeh M, Pourmoghaddam M.

Biol Trace Elem Res. 2009 Jul;130(1):1-6. doi: 10.1007/s12011-008-8309-2. Epub 2009 Jan 17.

PMID:
19148586
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk